Please login to the form below
OncoVex
This page shows the latest OncoVex news and features for those working in and with pharma, biotech and healthcare.
AZ signs yet another cancer immunotherapy deal
The most advanced is Amgen's OncoVex (talimogene laherparepvec), which in 2013 became the first oncolytic virus to show efficacy in a phase III trial involving people with the skin cancer
Latest news
-
Amgen says viral melanoma therapy clears phase III trial
OncoVex demonstrates durable response in skin cancer patients. A novel therapy for skin cancer which makes use of the cell-killing activity of a virus has shown efficacy in a phase ... The melanoma immunotherapeutic - talimogene laherparepvec (also known
-
Disease focus: Melanoma
nilotinib. In development. Vaccines. OncoVEX GM-CSF. In development. Vaccines. MAGE-A3 ASCI.
-
Amgen to buy BioVex
BioVex's portfolio includes OncoVex (GM-CSF) – an investigational vaccine to treat melanoma and head and neck cancer. ... Philip Astley-Sparke, CEO, BioVex, also praised the agreement: "Amgen is ideally positioned to leverage the potential of OncoVEX
More from news
Approximately 1 fully matching, plus 3 partially matching documents found.
Featured jobs
- Scientific Director - Medical Education - Cheshire & London ...
-
Excellent Remuneration Package
- Senior / Principal Medical Writer – Medical Education - UK &...
-
Excellent Salary and Benefits on offer
- Scientific Director - Medical Communications Agency - New York
-
Excellent Remuneration Package
- Graduate / Entry Level Opportunities – Medical Communications – ...
-
Highly Competitive Remuneration Package
- Experienced / Senior Medical Writer - MedComms - Cardiff - Wales
-
Excellent Salary and Benefits on offer
-
Senior Medical Writer
-
Salary TBC
- Senior Medical Writer – Leading Medical Communications Agency – ...
-
Highly Competitive Remuneration Package
-
Account Director, Medical Education
-
Salary TBC
- Account Manager / Senior Account Manager - Creative MedComms - C...
-
Excellent Remuneration
- Senior Medical Writer– Medical Education – Oxford - London
-
Excellent Remuneration Package
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
Subscribe to our email news alerts
- Moving annual total (MAT)
- Genital herpes vaccine candidate heads for human studies
- Novartis highlights emerging assets and late-stage pipeline at R&D day
- Pfizer takeover rumour ignites Amarin shares
- Creativity in storytelling: why pharma must invest more in creativity
- PMEA - Pharmaceutical Market Excellence Awards
- Biogen defends aducanumab filing plan amid scepticism
- UCB’s bimekizumab beats AbbVie’s Humira in phase 3 trial
- Novartis strengthens case for its combination asthma drug
- OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
- Sage slides off a MOUNTAIN as depression drug flunks trial
- Blind man's buff
PMHub
Aptus Health
Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...
Latest intelligence
- OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
- Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...
- Language barriers: Obesity has become a loaded word
- ...
- Spotlight interview: 15 minutes on digital in medical communications
- Gemma Allen, Head of Digital Communications, OPEN Health takes 15 minutes to answer some key questions on digital in medical communications...
Quick links
Infographics
